Pre-settlement funding for mass tort claims.
Multi-plaintiff litigation involving pharmaceutical injuries, defective devices, environmental contamination, and consumer products. Each plaintiff within a mass tort proceeding is reviewed individually.
Non-recourse funding is repaid only from a settlement or award. Independent capital providers set the terms.
Bills do not wait for your case.
Rent, medical bills and living costs keep arriving while a case moves through the court. An advance against a pending case can cover them and is repaid only if the case produces a recovery.
How mass tort cases are reviewed
Mass tort litigation involves a large number of plaintiffs with similar claims against a common defendant — typically a pharmaceutical manufacturer, medical device company, or industrial polluter. Individual plaintiffs within a mass tort often face years of litigation, limited visibility into case timeline, and ongoing financial pressure. Pre-settlement funding for mass tort plaintiffs provides individual, non-recourse advances based on each plaintiff's specific claim, independent of the overall mass tort resolution timeline.
What makes a qualifying case
Not every claim is a fit for funding. These are the factors our review weighs most heavily for this case type. Meeting them does not guarantee that a provider will fund.
Requirement 1
Active enrollment in the mass tort with retained counsel
Requirement 2
Documented product use or exposure and corresponding injury
Requirement 3
Completed plaintiff fact sheet and supporting medical records
How terms are set
Rates and terms are set by the capital provider and written in the provider’s agreement before signing.
How the process works for mass tort claims
- STEP 1ApplyApply individually. Mass tort cases are reviewed plaintiff by plaintiff, and each request is case-specific.
- STEP 2EvaluationWe assess your individual injury, the status of the mass tort, and your attorney's estimate of individual recovery.
- STEP 3Provider decisionIndependent capital providers review the file, decide whether to fund and set their own terms. Criterica Capital does not make the funding decision.
- STEP 4Provider agreementIf a provider funds the case, the provider's agreement states how and when funds are paid.
How we underwrite this case type
Mass tort advances are underwritten on a plaintiff-by-plaintiff basis, independent of the overall settlement timeline. We assess the procedural posture of the MDL, the strength of the underlying science, and the documentation supporting your individual claim, then estimate your expected individual recovery against the settlement and grid history of comparable mass torts. Because resolution can be years away, the timeline is priced explicitly into the advance.
Mass tort matters frequently take three to seven years from filing to individual distribution, depending on bellwether outcomes and global settlement timing.
Mass Tort Funding by state
Statutes of limitations, comparative-fault rules and damages caps for this case type vary by state. Select a state for the rules that apply.
Mass Tort Funding: common questions
Yes. Cases consolidated in multidistrict litigation (MDL) are fundable. We assess your individual claim value and the overall MDL status, including any global settlement discussions.
Pre-settlement funding can be sought at any stage of active litigation. Earlier-stage cases may support smaller advances, with more available as the litigation progresses toward resolution. Providers decide the amount.
Request funding for your case.
Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.